https://www.cnn.com/2021/04/07/world/coronavirus-n
Post# of 148326
Larger study on Long haulers. Might be a big deal that Leronlimab crosses the Blood Brain Barrier. 34% of a study of 236,000 patients shows some kind of brain disease. Our trial can’t get finished quick enough for these people. Then we start over with another trial... time is of the essence...